News and Insights of 3D Printing and Manufacturing
A research team at Missouri University of Science and Technology has developed a light-driven 3D printing technique designed to streamline the creation of organs-on-a-chip—tiny tissue-like devices used for drug testing and medical research.
Flying at high altitudes or traveling in space exposes the human body to extreme changes in pressure, temperature, and oxygen levels—environments that traditional cell cultures fail to mimic. Scientists at Texas A&M University have developed a 3D bioprinting method to study these effects.
Treating medical emergencies in space is challenging, as immediate care is limited and returning to Earth is both costly and time-consuming. To address these constraints, a research team led by Professor Park Chan-heum from Hallym University Chuncheon Sacred Heart Hospital has developed BioCabinet, a space biology research payload designed to produce living tissue in orbit and evaluate disease responses under microgravity conditions.
Scientists at the University of Virginia have introduced a new kind of 3D printable material that is compatible with the body’s immune system. The innovation is expected to support safer implantable devices, next-generation drug-delivery systems, and even improved solid-state batteries.
Researchers at the University of Sydney have developed 3D printed blood vessels on glass that replicate both the anatomy and fluid dynamics of real arteries. Published in Advanced Materials, the technology provides a new platform to study stroke mechanisms and test patient-specific medications.
US-based Boise State University researchers are developing a first-of-its-kind 3D printed device aimed at improving the accuracy of biomechanical testing in Boise, Idaho. Supported by the TRANSFORM Seed Grants Program part of the National Science Foundation’s ART award, the team plans to launch the tool commercially next year, advancing the translation of university research into real-world applications.
Researchers at Texas A&M University are developing a 3D printing approach to tackle a long-standing gap in pediatric care: the lack of safe, precisely measured drug doses for children. Led by Professor Mansoor Khan, the team is building hospital-ready technology designed to replace improvised liquid formulations with on-demand, accurately dosed tablets — a shift that is expected to improve treatment consistency and patient outcomes.
Ceramic 3D printing specialist Lithoz is using this year’s formnext to demonstrate that ceramic 3D printing has firmly entered industrial-scale production. The company’s Booth 11.1 C35 centers on real-world applications manufactured with its LCM technology across aerospace, semiconductors, medical devices and high-end consumer goods, underscoring how ceramic additive manufacturing (AM) is now being adopted in serial production environments.
Researchers at Swiss Federal Institute of Technology in Zurich. (ETH Zurich) have successfully 3D printed human muscle tissue in microgravity during parabolic flight experiments, marking a milestone in space-based biofabrication. The study aims to enhance disease modeling and drug development by recreating human tissues under gravity-free conditions that more accurately reflect the body’s natural architecture.
Tiger Aesthetics Medical, a division of Tiger Biosciences based in Conshohocken, Pennsylvania, has announced a strategic investment in GenesisTissue Inc, an early-stage biotechnology company developing personalized 3D bioprinting technologies for breast reconstruction and cosmetic surgery. The startup is creating solutions for both lumpectomy and mastectomy reconstruction, as well as aesthetic applications. This collaboration extends Tiger Biosciences’ regenerative medicine initiatives and follows the 2025 launch of alloClae, a ready-to-use structural adipose tissue product for body contouring.